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Abstract:  Intrinsically disordered proteins (IDPs) are a newly recognized class of 
functional proteins that rely on a lack of stable structure for function. They are highly 
prevalent in biology, play fundamental roles, and are extensively involved in human 
diseases. For signaling and regulation, IDPs often fold into stable structures upon binding 
to specific targets. The mechanisms of these coupled binding and folding processes are of 
significant importance because they underlie the organization of regulatory networks that 
dictate various aspects of cellular decision-making. This review first discusses the 
challenge in detailed experimental characterization of these heterogeneous and dynamics 
proteins and the unique and exciting opportunity for physics-based modeling to make 
crucial contributions, and then summarizes key lessons from recent de novo simulations of 
the structure and interactions of several regulatory IDPs. 
Keywords: conformational selection; generalized Born; implicit solvent; induced folding; 
molecular dynamics; p21; p27; p53; pKID; replica exchange 
 
1. Introduction 
The prevalence and fundamental roles of intrinsically disordered proteins (IDPs) in biology were 
not recognized until the late 1990s. Observations accumulated that many functional proteins, 
particularly those involved in transcription and translation regulation, appeared to be intrinsically 
unstructured [1]. This prompted Wright and Dyson to publish their seminal review in 1999 [2], calling 
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for a reassessment of the protein structure-function paradigm. Since then, study of IDPs has rapidly 
evolved into a field of “growing prominence” and “one of the most exciting undertakings of structural 
biology” as predicted [3,4]. It is now established that IDPs are: 1. highly abundant in biology, with 
about one-third of eukaryotic proteins predicted to be IDPs [5,6]; 2. frequently involved in crucial 
areas such as signaling and regulation [7–9]; and 3. extensively associated with human diseases 
including cancer, diabetes, neurodegenerative diseases and amyloidoses [10,11]. Many IDPs undergo 
folding transitions upon binding to specific targets [12], even though some IDPs remain unstructured 
in the bound states [13,14]. The mechanisms of these coupled binding-folding interactions are of 
significant importance because they underlie the organization of important regulatory networks that 
inform various aspects of cellular decision-making, cellular fate, and cellular signaling. Diseases and 
disorders can result from IDP mis-folding as well as mis-signaling and mis-regulation [11]. While the 
prevalence of IDPs as functional proteins was not fully recognized until the 1990s as stated above, one 
reviewer pointed out several pieces of work that were early hargingers. To illustrate this, three 
examples have been chosen here from a much larger collection. As early as 1953, optical rotation 
suggested that the milk protein casein is similar to globular proteins unfolded by 5 M guanidinium 
hydrochloride [15]. By the mid-1960s, optical rotation was used to develop a conformational 
classification of proteins, which included proteins that were characterized as disordered [16]. By the 
early 1970s, studies on fibrinogen strongly indicated that this protein contained large regions that lack 
structure [17], and more recently, this early history was reviewed in a very interesting fashion [18]. 
For signaling and regulation, the disordered nature of IDPs is believed to offer several unique 
advantages [2,3], including high specificity/low affinity binding, inducibility by posttranslational 
modifications, and structural plasticity for binding multiple targets. The last property appears to be a 
hallmark of IDPs that allows one-to-many and many-to-one signaling [19,20]. Intrinsic   
thermo-instability can also offer a robust mechanism for allosteric coupling [21]. However, the 
molecular mechanism of the coupled binding and folding interaction of IDPs has remained largely 
elusive except in a very small number of cases [22–24]. In particular, while it is recognized that 
residual structures often persist in unbound IDPs [7], their functional implications are under much 
debate [25]. Clearly, the extent of residual structure modulates the entropic cost of folding, and thus 
affects the binding affinity. It has been further proposed that preformed structural elements might serve 
as initial contact points and facilitate IDP folding on the substrate surface [26,27]. On the other hand, 
increasing the amount of local structures in the unbound state actually reduces the binding rate for 
several IDPs [28,29], emphasizing the importance of intrinsic flexibility in facile recognition of IDPs.  
Important progresses have been made over the last ten years or so in prediction, identification and 
general characterization of IDPs [30–34]. In particular, sequence analysis can be quite reliable applied 
to predict disordered protein segments with averaged sensitivity and specificity scores greater than 
0.8 [35]. The Database of Protein Disorder (DisProt, version 5.3, 09/21/2010) currently contains 1,284 
experimentally verified disordered regions within 594 proteins, and over forty atomistic structures of 
IDP complexes are now available [36]. One of the key challenges in IDP research at present is to 
understand mechanistically how intrinsic flexibility is exploited together with nascent structures and 
other biophysical signatures of IDPs for biological functions such as efficient and versatile binding. 
Such understanding is necessary for deciphering the elaborate physiological control of IDP function 
and how such control might fail in human diseases. This review will discuss the key challenges in Int. J. Mol. Sci. 2010, 11                 
 
 
5294
experimental characterization of unbound IDPs, how physics-based de novo simulations might help to 
provide important missing details of IDP structure and interaction, and important lessons that have 
been derived from a limited number of recent de novo simulations of regulatory IDPs. We note that a 
significant amount of computational work exists on studies of disordered proteins involved in protein 
aggregation and amyloidogenesis [37]. This review focuses on signaling and regulatory IDPs that often 
undergo coupled binding and folding during function. Studies of amyloidogenic proteins will only be 
discussed in the context of common challenges and opportunities for de novo simulations.  
2. Challenges in Detailed Experimental Characterization of IDPs 
Structural information of the bound state alone is not sufficient to establish biologically relevant 
regulatory mechanisms. For IDPs, the nature of the unbound state holds important clues to function. 
Due to the heterogeneous and dynamical nature, detailed characterization of unbound IDPs has proven 
to be a principal challenge. Consequently, a lack of understanding of the nature of residual structures 
in unbound IDPs hinders further clarification of their functional roles. Among a wide range of 
biophysical techniques available for characterizing disordered protein states [34], biomolecular NMR 
is probably the most comprehensive [38]. Many observables can be measured for multiple sites 
throughout the protein to infer (transient) organizations at the secondary and tertiary levels, including: 
chemical shift, coupling constant, nuclear Overhauser effect (NOE), residual dipolar coupling (RDC), 
paramagnetic resonance enhancement (PRE), and spin relaxation. Chemical shifts, coupling constants 
and NOEs can be used to determine secondary structure propensities semi-quantitatively at the residue 
level [39–42]. PRE and RDC are powerful tools for uncovering the existence of transient tertiary 
organizations [43–45]. They have been applied to derive important insights on many disordered 
protein states (see recent reviews [7,38,46,47]). However, a quantitative, structural interpretation of 
these experimental observables measured on unbound IDPs is generally not feasible. A key issue is 
that only ensemble-averaged properties can be measured in general and they must be represented as 
averaged quantities of a heterogeneous structure ensemble. Coupled with typical scarcity of data, the 
structural calculation is severely underdetermined and a unique structure ensemble cannot be 
determined solely from the experimental restraints. This critical limitation has not been fully 
appreciated in the literature. Certain intrinsic properties of RDC and PRE further complicate the 
structural interpretation. For example, PRE is extremely sensitive to the electron-nucleus distance with 
r
 dependence [48]. While such sensitivity allows detection of weakly populated transient contacts, it 
also renders PRE largely insensitive to the majority of accessible conformations. Using theoretical 
PRE data sets derived from simulated disordered protein states, we recently demonstrated that 
ensemble structural calculation protocols with PRE distance restraints [49,50] could generate 
misleading ensembles that reflect little on the true underlying protein state [51]. Direct incorporation 
of RDC in disordered ensemble calculation has not been feasible because of the intricate relationship 
between observed data and individual ensemble structure, even though strategies exist for globular 
proteins [52–54]. Thus, RDC has been mainly used for validation of various (coil) models of unfolded 
states [55,56] or as filters to select conformations from pre-generated structural pools [57,58]. 
Importantly, this general difficulty in structural interpretation arises mainly from the fundamental 
limitations of ensemble-averaged properties measured on disordered protein states rather than Int. J. Mol. Sci. 2010, 11                 
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technical ones. There is simply not sufficient constraint for independent identification of representative 
ensembles from experimental restraints alone. A few exceptions may include cases where additional 
information on the accessible conformational substates is available or can be assumed [59,60], or 
where unusually large amount of experimental data were measured [61].  
3. Opportunities and Challenges for de Novo Simulations  
The substantial challenge in detailed experimental characterization of IDPs presents a unique and 
exciting opportunity for molecular modeling to make critical contributions. In particular, atomistic 
simulations using physics-based empirical molecular mechanics force fields [62,63] arguably provides 
the ultimate level of detail necessary for understanding disordered protein states. The experimental 
data can be the used as independent validation of simulated ensembles instead of as restraints. Such a 
strategy avoids the under-determined structural calculation problem that tends to generate a false sense 
of excellent agreement with experiment. At the same time, the dynamic and unstructured nature of 
IDPs also presents substantial new challenges, pushing the limit on both force field accuracy and 
conformational sampling capability. Traditional explicit inclusion of water molecules arguably 
provides the most realistic description of solvent, but also significantly increases the system size   
(~10–fold). This can lead to prohibitive computational cost if one wants to sufficiently sample the 
broad manifold of functionally relevant states of IDPs. Moreover, mainly optimized for folded native 
states, current explicit solvent protein force fields are known to suffer from systematic biases in 
describing peptide conformational equilibria, such as tendency to over-stabilize helices [64,65] and 
peptide-peptide interactions [66]. These existing force field limitations need to be carefully considered 
in simulations of IDPs. Thanks to development of powerful computational hardware and advanced 
sampling techniques, important advances are being made recently in optimization of explicit solvent 
protein force fields [67–69]. Nonetheless, correcting the systematic biases in a consistent and 
transferable fashion has been difficult, and the computational cost is one of the main obstacles. 
Alternatively, implicit solvent has emerged as a powerful approach for atomistic simulation of 
protein conformational equlibria that provides a balance between description of the essential physics 
and computational feasibility [70]. The principle and practice of implicit solvent is well documented 
[70,71]. The basic idea is to capture the mean influence of water on the solute via direct estimation of 
the solvation free energy. As such, only the solute is represented atomistically, and the system size is 
reduced ~10-fold. Important advances have been made recently to greatly improve the efficiency and 
achievable accuracy of implicit solvent, particularly with the generalized Born (GB) approximation. 
For example, protein simulations in the GBSW implicit solvent is ~30 times faster than equivalent 
ones in explicit water [72]. Importantly, a substantial gain in efficiency allows careful optimization of 
implicit solvent protein force fields to suppress certain systematic biases that have plagued explicit 
solvent ones [62]. The key is to capture the delicate balance of competing solvation and intramolecular 
interactions on the peptide and protein level. We recently re-balanced the GBSW protein force field 
based on pair-wise interactions of side chain analogs and conformational properties of model peptides 
[73]. The optimized force field does not only recapitulate the experimental structures and stabilities of 
several helical peptides and a series of -hairpins with a wide range of stability, but also folds hairpin 
trpzip2 and mini-protein Trp-cage [73]. The same force field has also been successfully applied to pKa Int. J. Mol. Sci. 2010, 11                 
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prediction [74], pH-dependent protein folding [75–77], structure refinement [78], and recently to 
simulation of regulatory IDPs [79,80]. Similar optimization efforts have also led to substantial 
improvement in other GB models [81,82]. An ABSINTH implicit solvent has also been developed and 
optimized specifically for IDPs [83].  
It is important to recognize that inherent and methodological drawbacks do exist in implicit solvent 
[70]. They need to be carefully considered in the interpretation of implicit solvent simulations. This is 
particularly important considering that validation based on ensemble-averaged properties is not 
conclusive because of the same reasons detailed above for difficulty in structural calculations. Implicit 
solvent will not properly describe short-range effects where the detailed interplay of a few   
non-bulk-like water molecules is important. With a lack of solvent granularity, continuum models do 
not capture all the fine structures in potentials of mean force (PMFs) of interactions [73,84], and the 
conformational diffusion kinetics is altered. The temperature dependence cannot be described 
accurately in general either. Besides these intrinsic limitations, implicit solvent might be further 
limited by the specific methodology for calculating the solvation free energy as well as the physical 
parameters of the solvation model and underlying protein force fields. In particular, the surface-area 
(SA)-based treatment of nonpolar solvation appears to be a key methodological limitation in the 
current GB implicit solvent [85,86]. Nevertheless, a substantial reduction in the computational cost 
without compromising the essential physics is an important advantage of implicit solvent. By taking 
care in interpretation and validation of simulations, one can expect that de novo simulations to provide 
reliable details on the structure and interaction of IDPs. 
Even with the dramatic reduction in system size using implicit solvent, it is challenging to 
sufficiently sample biologically accessible, functionally relevant conformational space of IDPs. 
Conventional constant temperature molecular dynamics (MD) is generally insufficient for achieving 
convergence in simulated structural ensembles of IDPs. The difficulty arises not only because of the 
large and complex conformational space of proteins, but also due to significant energy barriers that 
might separate different conformational subspaces. It is necessary to exploit various advanced 
techniques to enhance sampling [87,88]. One particularly simple yet effective technique is replica 
exchange (REX) [89]. The basic idea is to simulate multiple independent replicas of the system at 
different temperatures, typically distributed exponentially between the temperature of interest and a 
maximum temperature. Periodically, replicas attempt to exchange simulation temperatures according 
to a Metropolis criterion that preserves the detailed balance and ensures proper canonical ensembles at 
all temperatures. The resulting random walk in the temperature space helps the system to avoid being 
kinetically trapped in states of local energy minima. The required number of replicas increases with 
the system size N (as a function of its squared root [89]). With ~10-fold smaller system size, implicit 
solvent is thus particularly suitable for REX. Recent theoretical considerations [90–92] and actual 
simulations of small peptides [93–96] generally confirm that REX can enhance protein conformational 
sampling as long as the activation enthalpies (of conformational transitions) are positive. In particular, 
it is important to specify a maximum REX temperature slightly above where the folding rate 
maximizes [91,92]. The key to obtain well-converged structural ensembles of IDPs is efficient 
sampling of transitions between conformational substates. However, the nature of these substates and 
the energy barriers of their inter-conversion are not known. Therefore, the efficacy of REX for IDPs is 
not very obvious, nor is the optimal choice of key REX-MD parameters such as the number of Int. J. Mol. Sci. 2010, 11                 
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replicas, range and distribution of simulation temperatures and exchange attempt frequency. On the 
other hand, several recent experimental studies suggest that the average roughness of protein energy 
surface likely exceeds 5 RT [97–99], which can lead to a strong temperature dependence of 
conformation diffusion [100]. The roughness consideration argues strongly for the general ability of 
REX to enhance sampling of protein conformations including those of IDPs.  
Another particularly attractive approach to overcome the sampling bottleneck is to combine large 
numbers of equilibrium and/or generalized ensemble simulations (e.g., on distributed computing 
platforms [101]) using network methods like the Markov State Models (MSMs) [102–104]. Even 
though it is yet to be applied to IDPs, this strategy has provided unprecedented detail on energy 
landscapes of several proteins under both stable and unstable conditions [105–107]. It is important to 
emphasize that sampling efficiency also strongly depends on the force field quality. In particular, 
modern protein force fields, with explicit or implicit solvent, tend to overestimate the strength of 
protein-protein interactions [66]. Consequently, non-specific collapsed protein states are often over-
stabilized, which severely hinders conformational sampling. When the goal is not to generate proper 
thermodynamic ensembles at physiological temperatures, temperature-induced unfolding/unbinding 
simulations can be used to infer on the mechanism of coupled binding and folding of IDPs given the 
complex structures. This strategy has been quite successful in studies of protein folding [108,109], and 
has already been applied to understand IDP interactions [110,111]. An interesting advantage of   
high-temperature simulations is that they are less sensitive to imperfections in the force fields, besides 
reduced computational cost. A key concern is that the transition states or the most probable transition 
paths might depend on the temperature. However, IDP complexes tend to be less stable than globular 
ones, and the temperature required for unbinding simulations will likely be moderate.  
4. Key Lessons from Recent de Novo Simulations of Regulatory IDPs  
4.1. Unbound IDPs: Nascent Structures and Dependence on Post-Translational Modifications 
As discussed above, the nature of the unbound state of an IDP holds important clues to how it might 
interact with specific targets. Abundant experimental evidence exists to suggest that various levels of 
residual structures persist in unbound IDPs. Such examples include several domains of transcription 
factor CREB [7], activation and regulatory domains of tumor suppressor p53 [112–114], the steroid 
receptor coactivator ACTR [115], the synuclein family [116,117], and cyclin-dependent kinase (Cdk) 
regulators p21 and p27 [118,119]. A key goal of de novo simulations of IDPs has thus been to provide 
molecular detail of such residual structures in unbound IDPs. In the following, we summarize key 
results from several recent de novo simulations of free regulatory IDPs where the goal is to understand 
coupled binding and folding. We note that physics-based simulations have also provided important 
insights into the intrinsic conformational properties of IDPs and how they might depend on certain 
physiochemical properties [120,121]. In particular, IDPs are known to have low sequence complexity 
with enriched charges. Several recent studies have shown that the structure of IDPs is correlated with 
the charge content [121,122]. It has been further suggested charges on IDPs can directly affect 
function, in both protein-DNA [123] and protein-protein interactions [80].  
The kinase-inducible domain (KID) of CREB is one of the most extensively studied IDPs. In cell, 
CREB regulates transcription in response to cAMP signaling partially by binding to the coactivator Int. J. Mol. Sci. 2010, 11                 
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CBP (CREB binding protein) [124]. This recognition requires phosphorylation of Ser133 of KID 
(pKID) and involves direct interaction with the KIX domain of CBP [125,126]. When in complex with 
KIX, pKID adopts a helix-linker-helix structure that involves residues 119 to 146 [127]. However, free 
KID and pKID lack stable tertiary structures in solution. NMR chemical shift analysis has estimated 
that helix A (residues 120–129) is about 50-60% folded and helix B (residues 134–144) is only  
10–15% formed [128]. Furthermore, secondary chemical shift analysis does not reveal significant 
differences in mean residue helicities upon phosphorylation [128]. Accordingly, the principal role of 
pSer133 has been attributed to mediating intermolecular interactions. Slot et al. have investigated the 
intrinsic structural properties of the unbound KID and pKID using explicit solvent MD simulations 
[129]. It was argued that phosphorylation could reduce the loop flexibility connecting two helices in 
the bound structure and induce a transient structural element that resembles native-like conformation. 
However, these simulations were conducted by using a simulated annealing protocol in explicit 
solvent. The total simulation length is only 2.0 nanoseconds (ns) with the last 1.0 ns as the production 
stage at 300 K. This is too short to sufficiently sample relevant conformations in the disordered state, 
as reflected in the narrow backbone  distributions reported [129]. Persistence of native-like loop 
conformation in pKID could be an artifact of limited sampling initiated from the folded structure. This 
concern substantially weakens the reliability of the proposed effects of phosphorylation.   
Well-converged structural ensembles of KID and pKID were later calculated using 200-ns REX-MD 
simulations in the optimized GBSW force field [73]. The simulated ensembles are mainly validated by 
comparing the mean residue helicities with the NMR results. Further structural analyses show that both 
KID and pKID are compact and mainly occupy a small number of helical substates (see Figure 1). 
Interestingly, even though in agreement with NMR pSer133 only leads to marginal helicity changes on 
the ensemble level, the underlying conformational substates differ significantly. In particular, pSer133 
appears to restrict the accessible conformational space of the loop connecting two helical segments and 
thus can reduce the entropic cost of KID folding upon binding to KIX. This entropic contribution 
supplements the salt-bridge interactions between KID pSer133 and KIX Lys662 and Tyr658. 
Replacing pSer133 with a Glu residue fails to induce similar structural changes (see Figure 1c). This 
explains why KID S133E does not bind to KIX nearly as strong as pKID [130], even though Glu can 
interact with similar strength with Lys or Tyr [131]. However, in contrast to Slot et al.’s simulations, 
pS133 does not appear to induce native-like loop conformations. The expanded role of 
phosphorylation in regulating the KID/KIX recognition was not recognized in the NMR studies due to 
lack of experimentally detectable conformational changes on the ensemble level. This highlights the 
importance of combining simulation and experiment for detailed characterization of unbound IDPs. 
The ability of well-converged de novo simulations to “predict” important features of the disordered 
states of a 28-residue IDP is nontrivial and represents an encouraging progress towards accurate 
simulation of IDP conformational equilibria. Int. J. Mol. Sci. 2010, 11                 
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Figure 1. 2D probability distributions of helix starting positions and lengths in the 
unbound structure ensembles of (a) KID, (b) pKID and (c) KID S133E at 302 K calculated 
from REX-MD folding simulations in GBSW implicit solvent [79]. Contours are drawn at 
0.002, 0.005, 0.01, 0.02, 0.04, and 0.06 levels. 
 
REX-MD simulations in implicit solvent have also been used to compute the structure ensemble of 
unbound p53 extreme C-terminus [80]. The results demonstrate that the free p53 peptide samples 
several distinct conformations, which, importantly, correspond to those experimentally observed when 
bound to different partners [19]. Presence of folded-like nascent structures has also been suggested in 
integrated computational and experimental studies of several other regulatory IDPs. Kriwacki and 
coworkers combined NMR data with a 100-ns explicit solvent simulation and suggested that   
sub-domains within free p27 kinase inhibitory domain exhibit partially folded nascent structures that 
resemble the bound conformation observed in the ternary complex of p27/Cdk2/cyclin A [118]. Yoon 
et al. characterized the residual structural elements of the C-terminal segment of p21, also using a 
combination of NMR and MD simulations, and identified helical and extended conformations that 
resemble those in complex with either calmodulin or proliferating cell nuclear antigen (PCNA) [119]. 
However, the role of nascent structures within these free IDPs in binding is not obvious, even though 
one might be tempted to speculate that such preformed structures might facilitate binding by providing 
initial binding sites (i.e., conformational selection-like mechanisms) [26,27]. 
4.2. Mechanism of Coupled Binding and Folding: Intrinsic Flexibility vs. Preformed Structures 
Compared to studies of unbound IDPs, there are even fewer de novo computational analyses of the 
molecular mechanisms of coupled binding and folding of IDPs. This can be primarily attributed to 
much greater computational cost. Rigorous thermodynamic and/or kinetic characterization of coupled 
binding and folding of IDPs is generally not feasible. In a pioneering study, Verkhivker et al. 
investigated the mechanism of p27 binding to Cdk2/cyclin A using high-temperature unfolding and 
unbinding simulations with a simplified all-atom protein energy function with physics-motivated terms 
[132]. The calculated transition state ensemble (TSE) suggests an induced folding-like mechanism, 
where molecular recognition is initiated by formation of nonspecific encounter complexes with 
unstructured p27. This finding supports the “fly-casting” mechanism proposed by Wolynes and 
coworkers [133,134], which argues that nonspecific binding of unstructured conformations confers a 
kinetic advantage for binding. Another key lesson obtained from this study is that intermolecular 
interactions appear to dedicate the folding mechanism of p27 and overwhelm local folding preferences Int. J. Mol. Sci. 2010, 11                 
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in unbound p27. This conclusion might prove to be applicable to other regulatory IDPs. In particular, 
structural plasticity for adopting distinctive folded states is believed to be a hallmark of regulatory 
IDPs. Therefore, the binding partner ultimately determines the IDP topology in the bound state, i.e., 
intermolecular interactions do overwhelm local folding preferences of IDPs prior to binding. Indeed, 
induced-folding was also observed in a recent high-temperature simulation of pKID/KIX [135]. 
Figure 2. 2D free energy surface of the folding and binding of p53 to S100B(). Folding 
is described by the number of helical residues, and the binding by the center-of-mass (CM) 
separation [80]. Representative structures are shown for regions that correspond to the 
unbound, nonspecific contact, and bound states. Charged residues on p53 and near its 
binding site on S100B() are shown in sticks 
 
The only attempt to rigorously calculate the binding and folding free energy surfaces of IDPs 
reported so far is on the p53/S100B(ββ) interaction [80]. A protocol that combines REX and umbrella 
sampling was used, and several approximations were necessary to further reduce the computational 
cost even with implicit solvent. In contrast to the speculation of conformational selection based on the 
presence of substantial helical content in the unbound state, the calculated energy surfaces reveal that 
the p53 extreme C-terminus initially binds to S100B(ββ) in an unfolded conformation and then quickly 
folds - an example of induced folding (e.g., see the green path in Figure 2). The residual structure in 
the unbound state thus mainly modulates the binding affinity, while the intrinsic flexibility is critical 
for the binding rate. This study illustrates that the presence of folded-like conformations in unbound 
IDPs is not sufficient evidence to establish conformational selection. It is important to directly 
examine the thermodynamics and/or kinetics of coupled binding and folding for mechanistic 
characterization. This study also reveals important remaining limitations in the current implicit solvent 
force field, which does not only substantially over-estimate the interaction strength but also fails to 
predict the experimental structure as the global free energy minimum.  
5. Conclusions 
IDPs are an important class of functional proteins, with high abundance and fundamental roles in 
biology and broad association with human diseases. Important progresses have been made in the 
prediction, identification and high-level characterization of disordered protein segments. Nevertheless, 
much needs to be learned about the nature of the unbound state and the molecular mechanism of 
coupled binding and folding. Detailed experimental characterization of IDPs is challenging due to the Int. J. Mol. Sci. 2010, 11                 
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heterogeneous and dynamic nature. IDP thus represents an exciting opportunity for physics-based 
modeling to make critical contributions. At the same time, simulation of IDP presents substantial new 
challenges that push the limit on both protein force field accuracy and conformational sampling 
capability. New modeling strategies need to be explored to address these challenges. Implicit solvent, 
coupled with advanced sampling techniques, provides a particularly suitable means for de novo 
characterization of IDP structure and interaction with a necessary balance between accuracy and 
efficiency. Only a small number of de novo simulations have been reported on regulatory IDPs so far, 
reflecting the existence of substantial challenges in the current simulation methodologies. Nonetheless, 
important insights have been obtained on the nascent structures and how they might contribute to 
molecular recognition of IDPs. With the sampling limitation alleviated by ever-increasing computing 
power and sophisticated algorithms that exploit abundant computing resources, the critical bottleneck 
for physics-based simulations of IDPs is in the achievable level accuracy of current protein force 
fields. This underpins intensive ongoing efforts in improving the ability of explicit and implicit solvent 
protein force fields to describe protein conformational equilibria. It is important to diligently validate 
de novo simulations using available experimental data and proper (positive and negative) controls. We 
anticipate an integrated computational and experimental strategy to address specific questions on the 
structure and interaction of biologically important IDPs, and are excited by the unique role that 
physics-based simulations will be expected (and required) to play. 
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